Organization

Knoa Pharma

Company that took over Purdue Pharma’s operating assets under the 2025 bankruptcy plan.

2 links, 0 backed by primary records

Play the story Explore connections

Connections 2

involved in

headquartered in

Proof 2 sources
  1. Purdue Pharma completes chapter 11 restructuring, Davis Polk & Wardwell LLP (counsel to Purdue Pharma), May 2026. Self-published
    As of the effective date, substantially all of the company’s operating assets were transferred to Knoa Pharma LLC
  2. Purdue Pharma dissolved as $7.4B opioid settlement takes effect; CT to receive $64M, Hartford Business Journal, 4 May 2026. Scholarship & press
    As part of the restructuring, Purdue’s operations have been transferred to a newly formed company, Knoa Pharma LLC, which began operating May 1.
    Knoa Pharma, based in Stamford, is owned by a nonprofit foundation and governed by independent leadership with no prior ties to Purdue, according to a company announcement.
Page history 1 change
  1. Add 55 stories, each checked against its sourcesAlibek96e92fe6

Something wrong or missing? Tell us, with a source, or edit this page.